Delayed response and survival from NovoTTF-100A in recurrent GBM.

@article{Villano2013DelayedRA,
  title={Delayed response and survival from NovoTTF-100A in recurrent GBM.},
  author={John L Villano and Leena E Williams and Karriem S. Watson and Nandini Ignatius and Marquess T Wilson and Tibor Valyi-Nagy and Edward A Michals and Herbert H. Engelhard},
  journal={Medical oncology},
  year={2013},
  volume={30 1},
  pages={338}
}
We present a 48-year-old male with recurrent glioblastoma (GBM) who was enrolled in the NovoTTF-100A landmark phase III study and has been on device for >6 years. During this time, his magnetic resonance images demonstrated initial growth followed by a slow decrease in enhancement with continued residual disease. Long-term survivors in patients with recurrent GBM are rare, especially in the absence of definitive local treatment such as surgery or radiosurgery. We present the clinical, imaging… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.
4 Citations
8 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-8 of 8 references

Similar Papers

Loading similar papers…